I share your passion for access to equitable vaccines, which is why I was so pleased that we made the contribution to both the COVAX facility for self-financing countries and the AMC to assist low-income countries' access to the vaccine.
I would note that Canada contributed the same amount to the AMC that we did to the COVAX facility. Canada is the second-largest contributor to the COVAX facility, after the United Kingdom.
When it comes to the ACT Accelerator—which is with regard to access to vaccines, therapeutics, diagnostics and health systems—Canada is the fourth-largest contributor overall in the world at this point in time.
Obviously, when it comes to vaccines, we understand that this is going to be an ongoing process. We have been very involved with research and development, and we are having lots of conversations with Gavi, with the WHO, and with other partners involved in the ACT Accelerator process.
We're continuing to encourage other countries to also join and to increase their contributions. We will continue to have conversations to see what Canadian leadership will continue to look like within this facility.